ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 132275 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 132275; 2) Community: the network communities that were significantly associated with the response to NSC 132275; 3) Molecule: the relationships between components within communities and NSC 132275; 4) MDR: the compounds that were significantly associated with the NSC 132275.

NSC Compound Enrichment Correlation
NSC 651320 Null 0.0048681766467277 0.35535999
NSC 677268 Null 0.0048681766467277 0.40763717
NSC 685126 4-Piperidinone, 3,5-bis[(4-fluorophenyl)methylene]-, (E,E)- 0.0048681766467277 0.52735009
NSC 699168 Null 0.0048681766467277 0.35268287
NSC 705305 Null 0.0048681766467277 0.28549872
NSC 711175 Null 0.0048681766467277 0.15195331
NSC 732844 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2-fluorobenzene 0.0048681766467277 0.23836443
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.00550789647802199 0.38523989
NSC 258812 N,N-Dimethyldaunomycin hydrochloride 0.00550789647802199 0.42705568
NSC 302991 Camptothecin Derivative 0.00550789647802199 0.35908162
Total:100  Current:20    [First] [Prev] [Next] [Last]